Goodrx Cost Of Revenue from 2010 to 2025
GDRX Stock | USD 4.57 0.15 3.39% |
Cost Of Revenue | First Reported 2019-09-30 | Previous Quarter 28.8 M | Current Value 11.7 M | Quarterly Volatility 11.7 M |
Check Goodrx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Goodrx Holdings' main balance sheet or income statement drivers, such as Interest Income of 35.2 M, Depreciation And Amortization of 130 M or Interest Expense of 39.3 M, as well as many indicators such as Price To Sales Ratio of 4.0, Dividend Yield of 0.0599 or PTB Ratio of 3.94. Goodrx financial statements analysis is a perfect complement when working with Goodrx Holdings Valuation or Volatility modules.
Goodrx | Cost Of Revenue |
Latest Goodrx Holdings' Cost Of Revenue Growth Pattern
Below is the plot of the Cost Of Revenue of Goodrx Holdings over the last few years. Cost of Revenue is found on Goodrx Holdings income statement and represents the costs associated with goods and services Goodrx Holdings provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Goodrx Holdings' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Goodrx Holdings' overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue | 10 Years Trend |
|
Cost Of Revenue |
Timeline |
Goodrx Cost Of Revenue Regression Statistics
Arithmetic Mean | 24,716,712 | |
Geometric Mean | 14,248,814 | |
Coefficient Of Variation | 105.49 | |
Mean Deviation | 22,354,514 | |
Median | 6,035,000 | |
Standard Deviation | 26,073,925 | |
Sample Variance | 679.8T | |
Range | 70.9M | |
R-Value | 0.83 | |
Mean Square Error | 227.8T | |
R-Squared | 0.69 | |
Significance | 0.000072 | |
Slope | 4,539,984 | |
Total Sum of Squares | 10197.7T |
Goodrx Cost Of Revenue History
About Goodrx Holdings Financial Statements
Goodrx Holdings investors use historical fundamental indicators, such as Goodrx Holdings' Cost Of Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Goodrx Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Cost Of Revenue | 77 M | 41.9 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin |
Additional Tools for Goodrx Stock Analysis
When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.